Guest guest Posted October 13, 2010 Report Share Posted October 13, 2010 After the ban in Europe, restrictions in USA. India suspend the manufacture & import of Rosiglitazone (antidiabetic)on Oct. 7. It was reported that the drug produce commendable adverse cardiac events and bad lipid profiles. Please check the Drug Controller General of India messages. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.